Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Workshop

PHARM001 - (R)TTE analysis: MIDD applications, concept, methodology and NONMEM hands-on, Pharmetheus

Thursday, November 14, 2024
1:00 PM – 5:00 PM MST
Location: Mesquite & Noble

    Speaker(s)

  • Lena E. Friberg, PhD (she/her/hers)

    Professor
    Uppsala University, Sweden

    Disclosure(s): Pharmetheus AB: Consultant/Advisory Board (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Pierre Fabre: Employment (Ongoing)

  • Nastya Kassir, PharmD, PhD, FCP (she/her/hers)

    Senior Director & Distinguished Scientist
    Genentech
    San Francisco, California, United States

    Disclosure(s): No financial relationships to disclose

  • France Mentre, PhD, MD (she/her/hers)

    Professor of Biostatistics
    INSERM / Université Paris Cité
    Paris, Ile-de-France, France

    Disclosure(s): IPSEN: Consultant/Advisory Board (Ongoing); Pharmetheus AB: Consultant/Advisory Board (Ongoing); Roche: Grant/Research Support (Ongoing)

Disclosure(s):
Lena E. Friberg, PhD: Pharmetheus AB: Consultant/Advisory Board (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Pierre Fabre: Employment (Ongoing)
Nastya Kassir, PharmD, PhD, FCP: No financial relationships to disclose
France Mentre, PhD, MD: IPSEN: Consultant/Advisory Board (Ongoing); Pharmetheus AB: Consultant/Advisory Board (Ongoing); Roche: Grant/Research Support (Ongoing)
Objective of this workshop is to enhance attendees’ knowledge of time to event (TTE) and repeated TTE (RTTE) modeling in NONMEM, both in theory and practice. Target audience is students and/or pharmacometricians with no or limited experience with TTE/RTTE modeling.
Workshop Provides:
Day 1:
*Motivation for running survival analyses from a model-informed drug development perspective, with key speakers from academia and industry.
Day 2
*Introduction to general concepts and theory, typical TTE/RTTE analysis followed by data formatting and key aspects of graphical exploration of TTE/RTTE data.
*Detailed Insights to NONMEM code useful for the model development, such as standard and alternative function parameterization, implementation of exposure-response relationships and estimation of covariate effects.
*Overview of efficient simulation frameworks will be presented, with a focus on NONMEM coding and derived metrics to graphically communicate on. *Several hands-on sessions to help the attendees appreciate the specificities of TTE/RTTE models in terms of evaluation and diagnostics.

After the workshop the attendees will be able to understand, conduct and communicate TTE and RTTE modeling analyses.
For more information visit Pharmetheus webpage